John A. Belperio

Cytokines in innate host defense in the lung.

The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.

Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.

Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome.

Bronchiolitis obliterans syndrome complicating lung or heart-lung transplantation.

CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury.

Cancer CXC chemokine networks and tumour angiogenesis.

CXCR3+CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury.

The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury.

Chronic lung allograft rejection: mechanisms and therapy.

Evolving concepts and controversies in lung transplantation.

Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.

Type I immune response cytokine-chemokine cascade is associated with pulmonary arterial hypertension.

Usefulness of immune monitoring in lung transplantation using adenosine triphosphate production in activated lymphocytes.

Pathologic findings in lung allografts with anti-HLA antibodies.

CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts.

Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience.

Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation.

Amphiregulin contributes to airway remodeling in chronic allograft dysfunction after lung transplantation.

Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease.

Capillary Proliferation in Systemic-Sclerosis-Related Pulmonary Fibrosis: Association with Pulmonary Hypertension.

Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study.

Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study.

Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib.

Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study.

Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.

Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection.

Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.

Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort study.

Pulmonary sarcoidosis: A comprehensive review: Past to present.

Diagnostic alignment to optimize inter-rater reliability among lung transplant pathologists.

Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunction.

Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohort.

Rapid prediction of acute thrombosis via nanoengineered immunosensors with unsupervised clustering for multiple circulating biomarkers.